Keep an Eye on Common Risk Factors for Ocular Melanoma

Print icon

While malignant melanoma of the eye is quite rare — only about 2,500 cases are reported in the U.S. each year — precursors of this disease are quite common. One in 10 Caucasians will develop a mole under the retina (known as a “choroidal nevus”) during their lifetime.

“Many [moles in the eye] are benign and very low risk,” said Dr. Scott Walter of the Hartford HealthCare Cancer Institute’s Melanoma and Skin Cancer Center. “But some have higher risk characteristics and could transform into a true melanoma.”

Dr. Walter is one of two ocular oncologists practicing in Connecticut. He is the only one also trained as a retinal surgeon.

Dr. Walter focuses on tumors in the back of the eye that require the expertise of a retina specialist to manage effectively. He treats patients with uveal melanoma, the most common cancer that originates in the eye; cancers elsewhere in the body that have spread to the eye (most frequently breast and lung cancer); along with other mostly benign tumors that originate in the eye.

Sometimes a biopsy is required to confirm a diagnosis of eye cancer.

“I think it’s important to see a specialist who is comfortable performing a biopsy in such a sensitive location,” Walter said.

Most eye tumors develop under the retina, a delicate layer of tissue lining the inside of the eye that is responsible for vision. Minimally invasive biopsy methods and new molecular tests enable doctors to identify patients at risk of developing metastasis (spread of the disease to other organs).  Early detection is key.

“The cancer is less likely to have spread if we catch it early,” said Dr. Walter.

Many people with eye melanoma don’t have symptoms until the cancer becomes more advanced. According to the American Cancer Society (ACS), signs and symptoms of eye melanomas can include blurry vision or loss of vision, shimmering sparkles or flashes of light, a growing dark spot on the colored part of the eye (iris), and changes in the size and shape of the pupil.

According to Dr. Walter and the ACS, risk factors for eye melanoma include:

  • Race/ethnicity: The risk of intraocular melanoma is much higher in Caucasians and white Hispanics than in African Americans or Asian Americans.
  • Eye color: People with blue, green, or hazel eyes are somewhat more likely to develop melanoma of the eye than are people with brown eyes.
  • Age: Eye melanomas can occur at any age, but the risk goes up as people get older.
  • Certain inherited conditions: People with oculodermal melanocytosis (darker pigmentation around the eye), dysplastic nevus syndrome(many abnormal moles on the skin), or a family history of certain rare cancers (mesothelioma, renal cell carcinoma, and/or melanomas on non-sun exposed regions) may be at increased risk of developing eye melanoma.

Routine eye exams can help to stop the disease in its tracks. Patients found to have a mole under the retina should have a dilated eye exam every six to 12 months to monitor the condition. Those with symptoms or high-risk features should be referred to an ocular oncology specialist for further evaluation.

To connect with Dr. Walter or the Hartford HealthCare Melanoma and Skin Cancer Center call 860.524.2723.

What's New

Art Therapy

ART for Healing: Coping With Cancer Through Artistic Expression

When coping with a chronic illness such as cancer, patients and their caregivers can experience a range of complex emotions. Expressive arts and other forms of integrative medicine can be an important resource for people to learn coping strategies, express their feelings and help process experiences during early diagnosis, treatment and...

Truncal Lymphedema

When Breast Cancer Treatments Cause Truncal Lymphedema

Lymphedema, a collection of fluid that can cause swelling, is possible anywhere in the body but seems to be identified and addressed more commonly when it happens in an arm or leg. When persistent swelling occurs in the underarm, breast, or chest, patients will often decide to wait and see...

Breast Cancer Surgery

New: Radiofrequency Seeds Aid Breast Surgery, Improve Cosmetic Results

Not all breast disease can be felt, so surgeons have developed ways to mark the lump or lesion for more effective removal. At Hartford HealthCare, that process just got a lot more high-tech and efficient. This month, the Hartford HealthCare Cancer Institute Breast Program becomes the first in the state...

PSA test

How to Stop Prostate Cancer? It Starts With a PSA Test

Dr. Ryan Dorin, a urologist at the Hartford HealthCare Tallwood Urology & Kidney Institute, says the PSA test remains the best way to detect prostate cancer at its earliest stages and give the patient the best chance at successful treatment. Here’s a quick Q&A: Q: There has been a fair...


A Healthier You: Cancer Institute Summer Classes, Events

2019 Hartford HealthCare Cancer Institute Summer Calendar Bereavement Support Group June 26, July 10 & 24, Aug. 14 & 28 from 2-3:30 pm Hartford HealthCare Cancer Institute at Backus Hospital, 326 Washington St., Norwich, Conference Room 2 To register, call 1.855.HHC.HERE (1.855.442.4373) Brain Tumor Support: Upcoming Events and Community Resources June 6, July 11, Aug....

Rethinking Immunity to Help Beat Cancer

By Dr. Peter Yu Physician-in-Chief, Hartford HealthCare Cancer Institute It is frightening to receive a cancer diagnosis. But there is more hope than ever before. Through clinical trials and research, we are developing new treatments that help people live longer and better lives – and actually cure an increasing number of...